Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Borch-Johnsen, A. Neil, B. Balkau, S. Larsen, A. Nissinen, J. Pekkanen, S. Keinänen-Kiukaanniemi, L. Hiltunen, S. Kivelä, J. Tuomilehto, P. Jousilahti, J. Lindstrom, M. Pyorala, K. Pyörälä, E. Eschwège, G. Gallus, M. Garancini, A. Schranz, R. Heine, J. Dekker, E. Feskens, H. Lithell, B. Zethelius, M. Peltonen, N. Unwin, N. Ahmad, K. Alberti, M. Alberti, J. Eriksson, Q. Qiao (1999)
Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteriaThe Lancet, 354
(1979)
National Diabetes Data Group. Classification and diagnosis of diabetes and other categories of glucose intolerance
M. Coutinho, H. Gerstein, Y. Wang, S. Yusuf (1999)
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes care, 22 2
J. Sowers, Melvin Lester (1999)
Diabetes and cardiovascular disease.Diabetes care, 22 Suppl 3
G. Rose (1985)
Sick individuals and sick populations.International journal of epidemiology, 14 1
J. Quesada-Gomez, Ignacio Serrano-Alferez (2001)
Nonhypoglycemic effects of thiazolidinediones.Annals of internal medicine, 135 11
F. Vegt, J. Dekker, C. Stehouwer, G. Nijpels, L. Bouter, R. Heine (1998)
The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn StudyDiabetes Care, 21
B. Howard, M. Magee (2000)
Diabetes and cardiovascular diseaseCurrent Atherosclerosis Reports, 2
O. Vaccaro, G. Ruffa, G. Imperatore, V. Iovino, A. Rivellese, G. Riccardi (1999)
Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis.Diabetes care, 22 9
Dang Qing
Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The
H. Uchino, M. Niwa, T. Shimizu, K. Nishiyama, R. Kawamori (2000)
Impairment of early insulin response after glucose load, rather than insulin resistance, is responsible for postprandial hyperglycemia seen in obese type 2 diabetes: assessment using nateglinide, a new insulin secretagogue.Endocrine journal, 47 5
DeFronzo DeFronzo (1999)
Pharmacologic therapy for type 2 diabetes mellitusAnn Intern Med, 131
Q. Qiao, G. Hu, J. Tuomilehto, T. Nakagami, B. Balkau, K. Borch-Johnsen, A. Ramachandran, V. Mohan, S. Iyer, M. Tominaga, Y. Kiyohara, I. Kato, K. Okubo, M. Nagai, S. Shibazaki, Ze Yang, Zhifu Tong, Qinying Fan, B. Wang, S. Chew, B. Tan, D. Heng, S. Emmanuel, N. Tajima, Y. Iwamoto, C. Snehalatha, V. Vijay, A. Kapur, Yanhu Dong, H. Nan, Weiguo Gao, Haiyan Shi, Fangming Fu (2003)
Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts.Diabetes care, 26 6
K. Khaw, N. Wareham, R. Luben, S. Bingham, S. Oakes, A. Welch, N. Day (2001)
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)BMJ : British Medical Journal, 322
J. Ruige, J. Neeling, P. Kostense, L. Bouter, R. Heine (1997)
Performance of an NIDDM Screening Questionnaire Based on Symptoms and Risk FactorsDiabetes Care, 20
Melanie Davies, N. Raymond, J. Day, C. Hales, A. Burden (2000)
Impaired glucose tolerance and fasting hyperglycaemia have different characteristicsDiabetic Medicine, 17
T. Buchanan, A. Xiang, R. Peters, S. Kjos, A. Marroquin, J. Goico, C. Ochoa, S. Tan, S. Azen (2001)
Protection from Type 2 Diabetes Persists in the TRIPOD Cohort Eight Months after Stopping Troglitazone
M. Hanefeld, T. Temelkova-Kurktschiev, F. Schaper, E. Henkel, G. Siegert, C. Koehler (1999)
Impaired fasting glucose is not a risk factor for atherosclerosisDiabetic Medicine, 16
J. Tuomilehto, J. Lindstrom, S. Keinanen-Kiukaanniemie, L. Hiltunen, S. Kivelä, G. Gallus, M. Garancini, A. Schranz, L. Bouter, J. Dekker, R. Heine, G. Nijpels, A. Pająk, C. Castell, G. Lloveras, R. Tresserras, P. Pablos-Velasco, F. Martínez-Martín, F. Rodriguez-Perez, R. Gabriel, M. Serrano-Ríos, M. Pladevall, J. Muñiz, M. Eliasson, B. Stegmayr, V. Lundberg, N. Unwin, K. George, M. Alberti, L. Hayes, K. Borch-Johnsen, J. Eriksson, Q. Qiao, G. Hu, B. Balkau (2003)
Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts.Diabetes care, 26 1
E. Eschwège, M. Charles, Dominique Simon, N. Thibult, B. Balkau (2001)
Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study.Diabetes care, 24 11
A. Motala, Mahomed Omar, E. Gouws (1997)
Transient Impaired Glucose Tolerance in South African Indians Does Not Carry a Risk for Progression to NIDDMDiabetes Care, 20
J. Tuomilehto, J. Lindström, J. Eriksson, T. Valle, H. Hämäläinen, P. Ilanne-Parikka, S. Keinänen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Rastas, V. Salminen, S. Aunola, Z. Cepaitis, V. Moltchanov, M. Hakumäki, M. Mannelin, V. Martikkala, J. Sundvall, M. Uusitupa (2001)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.The New England journal of medicine, 344 18
M. Harris, R. Eastman, C. Cowie, K. Flegal, M. Eberhardt (1997)
Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980–1985 World Health Organization Diagnostic CriteriaDiabetes Care, 20
Q. Qiao, T. Nakagami, J. Tuomilehto, K. Borch-Johnsen, B. Balkau, Y. Iwamoto, N. Tajima, T. Group (2000)
Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohortsDiabetologia, 43
R. Dina, M. Jafari (2000)
Angiotensin II-receptor antagonists: an overview.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 57 13
W. Knowler, E. Barrett-Connor, S. Fowler, R. Hamman, J. Lachin, Elizabeth Walker, David Nathan (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.The New England journal of medicine, 346 6
C. Baan, J. Ruige, R. Stolk, J. Witteman, J. Dekker, R. Heine, E. Feskens (1999)
Performance of a predictive model to identify undiagnosed diabetes in a health care setting.Diabetes care, 22 2
T. Puoane, H. Bradley (2003)
Primary prevention of non-communicable diseases by community health workers : a case study of health and developmentAfricanus, 33
J. Gavin, K. Alberti, M. Davidson, R. DeFronzo, A. Drash, S. Gabbe, S. Genuth, M. Harris, R. Kahn, H. Keen, W. Knowler, H. Lebovitz, N. Maclaren, J. Palmer, P. Raskin, R. Rizza, M. Stern (1999)
Report of the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes care, 26 Suppl 1
H. Lithell, B. Zethelius (1998)
Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological dataBMJ, 317
A. Scheen (2001)
Thiazolidinediones and liver toxicity.Diabetes & metabolism, 27 3
(1995)
A Dictionary of Epidemiology, 3rd edn
(2002)
Acarbose can prevent the progression of impaired glucose tolerance to type 2 diabetes mellitus: results of a randomised clinical trial. The STOP-NIDDM randomised Trial
W. Rathmann, G. Giani, A. Mielck (1999)
Cardiovascular risk factors in newly diagnosed abnormal glucose tolerance: comparison of 1997 ADA and 1985 WHO criteriaDiabetologia, 42
M. Stern (1995)
Diabetes and Cardiovascular Disease: The “Common Soil” HypothesisDiabetes, 44
Markolf Hanefeld, C. Koehler, E. Henkel, Katja Fuecker, F. Schaper, T. Temelkova-Kurktschiev (2000)
Post‐challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima‐media thickness: the RIAD StudyDiabetic Medicine, 17
J. Shaw, P. Zimmet, M. Courten, G. Dowse, P. Chitson, H. Gareeboo, F. Hemraj, D. Fareed, J. Tuomilehto, K. Alberti (1999)
Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?Diabetes care, 22 3
K. Williams, J. Price, D. Kelley (2001)
Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography.Diabetes, 50 9
Xiao-ren Pan, Guang-wei Li, Ying-hua Hu, Ji Wang, Wen–ying Yang, Zuo An, Ze-xi Hu, Juan Lin, Jian-zhong Xiao, H. Cao, Ping Liu, Xi Jiang, Yayun Jiang, Jin Wang, Hui-E Zheng, Hui Zhang, P. Bennett, B. Howard (1997)
Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes StudyDiabetes Care, 20
A. Fontbonne, M. Charles, I. Juhan-vague, J. Bard, P. André, F. Isnard, J. Cohen, P. Grandmottet, P. Vague, M. Safar, E. Eschwège (1996)
The Effect of Metformin on the Metabolic Abnormalities Associated With Upper-Body Fat Distribution. BIGPRO Study GroupDiabetes Care, 19
S. Haffner, M. Stern, H. Hazuda, B. Mitchell, J. Patterson (1990)
Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?JAMA, 263 21
Momin Gabir, R. Hanson, D. Dabelea, G. Imperatore, J. Roumain, P. Bennett, W. Knowler (2000)
Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.Diabetes care, 23 8
J. Lindström, J. Tuomilehto (2003)
The diabetes risk score: a practical tool to predict type 2 diabetes risk.Diabetes care, 26 3
(1980)
Geneva: World Health Organisation
D. Dunstan, P. Zimmet, T. Welborn, M. Courten, A. Cameron, R. Sicree, T. Dwyer, S. Colagiuri, D. Jolley, M. Knuiman, R. Atkins, J. Shaw (2002)
The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.Diabetes care, 25 5
G. Ko, J. Chan, Jean Woo, C. Cockram (1998)
Use of the 1997 American Diabetes Association Diagnostic Criteria for Diabetes in a Hong Kong Chinese PopulationDiabetes Care, 21
S. Gimeno, S. Ferreira, L. Franco, M. Iunes (1998)
Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group.Diabetes care, 21 11
N. Wareham, C. Byrne, R. Williams, N. Day, C. Hales (1999)
Fasting proinsulin concentrations predict the development of type 2 diabetes.Diabetes care, 22 2
B. Rajendran (2001)
Impaired fasting glucose versus impaired glucose tolerance.The Journal of the Association of Physicians of India, 50
K. Hunt, K. Williams, S. Haffner, M. Stern (2002)
Predicting Impaired Glucose Tolerance (IGT) among Individuals with a Non-Diabetic Fasting Glucose Value: The San Antonio Heart StudyDiabetes, 51
H. Larsson, G. Berglund, F. Lindgärde, B. Ahrén (1998)
Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intoleranceDiabetologia, 41
(2002)
Bord-Johnsen K, for the DECODE Study Group. Age and sex specific prevalence of diabetes and impaired glucose regulation
M. Saad, W. Knowler, D. Pettitt, R. Nelson, P. Bennett (1988)
Transient impaired glucose tolerance in Pima Indians: is it important?British Medical Journal, 297
K. Borch-Johnsen, A. Neil, B. Balkau, S. Larsen, A. Nissinen, J. Pekkanen, J. Tuomilehto, P. Jousilahti, J. Lindstrom, M. Pyorala, K. Pyörälä, E. Eschwège, G. Gallus, M. Garancini, L. Bouter, J. Dekker, R. Heine, G. Nijpels, C. Stehouwer, E. Feskens, D. Kromhout, M. Peltonen, A. Pająk, J. Eriksson, Q. Qiao (2001)
Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.Archives of internal medicine, 161 3
Momin Gabir, R. Hanson, D. Dabelea, G. Imperatore, J. Roumain, P. Bennett, W. Knowler (2000)
The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.Diabetes care, 23 8
C. Weyer, C. Bogardus, R. Pratley (1999)
Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.Diabetes, 48 11
Helena Larsson, B. Ahrén (1998)
Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginineDiabetologia, 41
(2001)
Logistic regression model predicting the incidence of either diabetes or cardiovascular disease in the San Antonio Heart Study: a score sheet for risk assessment
J. Chiasson, R. Gomis, M. Hanefeld, R. Josse, A. Karasik, M. Laakso (1998)
The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.Diabetes care, 21 10
Reitsma Wd, J. Terpstra (1981)
[WHO Expert Committee on diabetes mellitus].Nederlands tijdschrift voor geneeskunde, 125 3
Diabetes, 28
J. Chiasson, Roman Gomis, M. Hanefeld, R. Josse, A. Karasik, M. Laakso (1998)
The STOP-NIDDM Trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening dataDiabetes Care, 21
S. Azen, R. Peters, K. Berkowitz, S. Kjos, A. Xiang, T. Buchanan (1998)
TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.Controlled clinical trials, 19 2
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais (2000)
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.The New England Journal of Medicine, 342
F. Vegt, J. Dekker, H. Ruhé, C. Stehouwer, G. Nijpels, L. Bouter, R. Heine (1999)
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn StudyDiabetologia, 42
D. Freeman, J. Norrie, N. Sattar, R. Neely, S. Cobbe, I. Ford, C. Isles, A. Lorimer, P. Macfarlane, J. Mckillop, C. Packard, J. Shepherd, A. Gaw (2001)
Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention StudyCirculation: Journal of the American Heart Association, 103
J. Chiasson, R. Josse, R. Gomis, M. Hanefeld, A. Karasik, M. Laakso (2002)
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 359
Gerson Lesser (2000)
Long-Term Prevention of Bone LossAnnals of Internal Medicine, 133
W. Thompson (2001)
Early recognition and treatment of glucose abnormalities to prevent type 2 diabetes mellitus and coronary heart disease.Mayo Clinic proceedings, 76 11
Contents Glossary of abbreviations 708 Abstract 709 Introduction 710 Aim and objectives of the workshop 710 Structure of the report 711 Background 711 The origin and nature of IGT and IFG categories 711 Definitions 711 Descriptive epidemiology of IGT and IFG 712 The predictive properties of IFG and IGT—methodological considerations 713 Predictive properties of IGT and IFG for diabetes 713 Predictive properties of IGT and IFG for cardiovascular disease and total mortality 714 Predicting CVD and diabetes as outcomes from a ‘common soil’ 716 Intervention studies in people with impaired glucose tolerance 717 Identifying and prioritizing people with IGT for intervention 718 Consensus statements and recommendations 720 The Definition and Status of IGT and IFG 720 Diseases, risk factors or risk markers? 720 Should we intervene? 720 Acknowledgements 721 Appendix — Workshop members 721 References 721
Diabetic Medicine – Wiley
Published: Sep 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.